Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
PZ HTL SA
GLOBETECH PUBLISHING LLC

Automated Cell Separation Achieved for Three Cell Types Simultaneously

By BiotechDaily International staff writers
Posted on 05 May 2014
Image: New LIAISON Ixt/Arrow CellSep Advanced provides rapid, automated cell separation for up to three cell types in a single run (Photo courtesy of DiaSorin).
Image: New LIAISON Ixt/Arrow CellSep Advanced provides rapid, automated cell separation for up to three cell types in a single run (Photo courtesy of DiaSorin).
The automated isolation of cells directly from whole blood or buffy coat is based on magnetic bead technology.

DiaSorin (Saluggia, Italy) has launched LIAISON Ixt/Arrow CellSep Advanced, which can isolate up to 3 cell types per sample in just 32 minutes per cell type, offering significant time savings compared to manual cell separation methods.

CellSep Advanced is designed for use on the LIAISON Ixt/Arrow instrument for the separation of 1, 2, or 3 cell types in up to 12 samples at a time. Requiring minimal hands-on intervention CellSep Advanced produces good yields of purified cell preparations ready for use in a wide range of downstream applications, including lineage-specific chimerism analysis. The Ixt/Arrow automated platform also minimizes human error and ensures reproducibility between runs for consistent and reliable downstream analysis.

The LIAISON Ixt/Arrow instrument can also be used for DNA extraction using the Ixt/Arrow Blood DNA extraction kit, ensuring streamlined processing of samples and, by reducing instrumentation requirements, saving valuable bench space in the laboratory.

DiaSorin is a leader in the field of biotechnology. For over 40 years the company has been developing, producing, and marketing reagent kits for in vitro diagnostics worldwide. With their most recent acquisition of the NorDiag Group, DiaSorin gains access to the nucleic acid isolation and cell separation markets. Its line of products used by diagnostic laboratories that are part of hospital facilities or operate independently (private diagnostic services laboratories) can meet the needs of the following clinical areas: infectious diseases, cardiac markers, bone metabolism, hepatitis and retrovirus, oncology, and endocrinology.

Related Links:

DiaSorin



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: This novel, flexible film that can react to light is a promising step toward an artificial retina (Photo courtesy of the American Chemical Society).

Novel Nanofilm May Be Artificial Retina Precursor

Researchers have used advanced nanotechnology techniques to develop a light-sensitive film that has potential for future artificial retina applications. Investigators at the Hebrew University of Jerusalem... Read more

Drug Discovery

view channel
Image: The new peptide offers a triple hormone effect in a single-cell molecule (Photo courtesy of Indiana University).

Tripeptide Drug Effectively Controls Metabolic Syndrome in Rodent Model

Promising results in reducing obesity and normalizing glucose metabolism obtained with a synthetic dipeptide drug have been enhanced by the addition of a molecule of a third hormone, glucagon.... Read more

Biochemistry

view channel

Blocking Enzyme Switch Turns Off Tumor Growth in T-Cell Acute Lymphoblastic Leukemia

Researchers recently reported that blocking the action of an enzyme “switch” needed to activate tumor growth is emerging as a practical strategy for treating T-cell acute lymphoblastic leukemia. An estimated 25% of the 500 US adolescents and young adults diagnosed yearly with this aggressive disease fail to respond to... Read more

Business

view channel

R&D Partnership Initiated to Reduce Development Time for New Drugs

nanoPET Pharma, GmbH (Berlin, Germany) signed an open-ended framework contract with the international pharmaceutical company Boehringer Ingelheim (Ridgefield, CT, USA). By developing customized contrast agents for research in both basic and preclinical studies, nanoPET Pharma will contribute to the enhancement of Boehringer... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.